The Impact of the Covid-19 Pandemic on New and Ongoing Clinical Trials
Navigating the COVID-19 Pandemic, Preparing for the Rest of 2020 & Planning a Return to "Normalcy" in the New Clinical Trial Landscape 

June 25 - 26, 2020 | Virtual Event

Heiner Gertzen

Head GxP Inspection & Audit Readiness Sanofi


  • Diploma (MSc) & Doctorate (PhD) in Experimental & Mathematical Psychology, University of Heidelberg
  • Diploma in Research Quality Assurance, Anglia Polytechnic University, Cambridge, United Kingdom

Prior Positions

  • 1985 Research Project Manager, University of Heidelberg & SEL Alcatel, Stuttgart, Germany
  • 1990 Head of the GCP Audit Group Europe, Hoechst AG, Frankfurt, Germany
  • 1995 Head of Corporate Regulatory Compliance Europe, Hoechst Marion Roussel, Frankfurt
  • 2000 Head of GCP-QA EU Operations Center, Aventis S.A., Antony / Paris, France
  • 2005 Director Clinical Quality Assurance Europe, Africa, Middle East, Sanofi-Aventis, France
  • 2010 R&D Quality Intelligence Leader, Sanofi, Chilly-Mazarin, France
  • 2016 Head of GxP Inspection & Audit Readiness, Sanofi, Chilly-Mazarin, France

Current Position (since 2018)

  • Medical & Clinical Expert - Global Medical, Clinical & Country Quality, Sanofi, Chilly-Mazarin, France

Check out the incredible speaker line-up to see who will be joining Heiner.

Download The Latest Agenda